King Pharmaceuticals®, Inc. Posts Q4 Loss on Charge, Lower Sales

February 26, 2009 |

1 min read

BOSTON, Feb 26 (Reuters) - King Pharmaceuticals Inc posted a fourth-quarter loss on Thursday as sales of its blood pressure drug fell and it took an acquisition-related charge.

Earnings

MORE ON THIS TOPIC

A bottle of a vaccine on a reflective surface with the illuminated red outline of the world map in red - 3D render

Vaccines

Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait

February 16, 2026

·

3 min read

·

Annalee Armstrong

Businessman on a crossroad. Man choosing career. Searching of right path. Decision and brainstorming concept. Flat vector illustration.

Earnings

Moderna’s FDA Challenges Stymie Breakeven Goal in ‘Fresh and Fluid’ Situation

February 13, 2026

·

5 min read

·

Annalee Armstrong

Adult people customers group in casual clothes standing in long line queue

Gene therapy

Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp

February 13, 2026

·

3 min read

·

Dan Samorodnitsky

Various white pills and capsules forming a map of the world, illustrating humanity's increasing dependency on medication manufacturing.

Obesity

Lilly Prepares $1B+ Orforglipron Stock Ahead of Approval as Novo Brings Wegovy Pill Overseas

February 13, 2026

·

2 min read

·

Tristan Manalac